𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Topisches Mitomycin C als Therapie konjunktivaler Tumore

✍ Scribed by M. Schallenberg; N. Niederdräing; K.-P. Steuhl; D. Meller

Publisher
Springer
Year
2008
Tongue
German
Weight
538 KB
Volume
105
Category
Article
ISSN
0941-293X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitomycin-C in the therapy of far-advanc
Mitomycin-C in the therapy of far-advanced malignant tumors
✍ Leon H. Manheimer; Jose Vital 📂 Article 📅 1966 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Forty-six patients with far-advanced malignancies, primarily of epithelial origin, were treated with intravenously administered mitomycin-C over a 4-year period. Several patients received more than one course of therapy. Thirty per cent of the patients demonstrated a transient, objective remission a

Sequential instillation therapy with mit
Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors
✍ Iwao Fukui; Hideaki Sekine; Kazunori Kihara; Takumi Yamada; Tsuneo Kawai; Makoto 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 346 KB

From October 1983 to September 1985, 84 patients with superficial bladder tumor (Ta, Tl, Tis) were treated with sequential instillation of mitomycin C (MMC) and adriamycin (ADM). Doses of 20 mg MMC on day 1 and 40 mg ADM on day 2 were instilled into the bladder and retained for at least 2 h; this wa

Combination therapy with mitomycin C, 5-
Combination therapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside for nonresectable malignant tumor in man
✍ Takayuki Yamaguchi; Masanori Nakamura 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

The effectiveness of MFC (mitomycin C, 5-fluorouracil and cytosine arabinoside) therapy for nonresectable cancers and cancers recurring after surgery was investigated in 60 patients with solid cancers aged 26 to 69 years. Treatment was effective in 28 patients (47%) including seven (12%) who showed